LNC 834Alternative Names: LNC 409 sulfate
Latest Information Update: 13 Dec 1994
At a glance
- Originator Procter & Gamble
- Class Cinchona alkaloids; Class Ia antiarrhythmics; Quinolines; Small molecules
- Mechanism of Action Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 14 Oct 1994 Discontinued-I for Arrhythmias in USA (PO)